Oct 30 |
Jim Cramer Thinks That Merck & Co., Inc. (MRK) Is ‘Too Low’
|
Oct 28 |
Why Is Moderna Stock Trading Higher On Monday?
|
Oct 28 |
Will These 5 Big Drug Stocks Surpass Q3 Earnings Forecasts?
|
Oct 28 |
Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)
|
Oct 28 |
Earnings week ahead: MSFT, AMZN, AAPL, META, GOOG, AMD, PFE, F, MCD, SBUX, XOM, CVX and more
|
Oct 27 |
Merck & Co., Inc. (MRK): Among the Best Dow Stocks to Buy According to Analysts
|
Oct 27 |
Wall Street Week Ahead
|
Oct 27 |
Merck & Co., Inc. (MRK): Among the Best Stocks to Buy for High Returns in 2024
|
Oct 26 |
M&A deals roundup: Merck, Seadrill, Kraft Heinz, Spirit Airlines and more
|
Oct 25 |
Merck Q3 Earnings Review: Solid Financials May Be Undermined By New Keytruda Threat
|